Rhode Island Hospital is pleased to offer a variety of pharmacy residency programs accredited by the American Society of Health-System Pharmacists (ASHP). Our programs include a PGY1 Pharmacy Residency and PGY2 programs in both Ambulatory Care and Oncology. PGY2 programs are offered in partnership with the College of Pharmacy at the University of Rhode Island. Starting in 2020, Rhode Island Hospital added a PGY1/2 Health-System Pharmacy Administration and Leadership Program, which is currently in Candidate Status for accreditation.
PGY2 Health-System Pharmacy Administration and Leadership Program Director
Christine Collins, MBA, RPh
Vice President, Chief Pharmacy Officer Ccollins2@lifespan.org
Residents are directed in skills critical to patient care, communication and leadership within a multidisciplinary health care team.
PGY1 pharmacy residency programs build on doctor of pharmacy (PharmD) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.
PGY2 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
PharmD degree from an accredited school/college of pharmacy